IOMEPROL INJECTION

IOMEPROL INJECTION was reported 1415 times

IOMEPROL INJECTION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HAEMATIDROSIS 3 0.1200
1 MITOCHONDRIAL ENZYME DEFICIENCY 5 0.1042
2 REEXPANSION PULMONARY OEDEMA 1 0.0833
3 AGEP-DRESS OVERLAP 2 0.0625
4 MENINGOENCEPHALITIS BACTERIAL 4 0.0270
5 AORTIC STENT INSERTION 1 0.0244
6 ADMINISTRATION SITE OEDEMA 2 0.0233
7 VASCULAR GRAFT INFECTION 1 0.0227
8 NASAL MUCOSAL BLISTERING 1 0.0185
9 POSTRESUSCITATION ENCEPHALOPATHY 1 0.0156
10 PARVOVIRUS B19 TEST POSITIVE 1 0.0141
11 CHEMICAL BURN OF RESPIRATORY TRACT 1 0.0128
12 PURPURA NON-THROMBOCYTOPENIC 1 0.0120
13 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 92 0.0118
14 SUSPECTED PRODUCT CONTAMINATION 11 0.0109
15 AGONAL RESPIRATION 3 0.0106
16 RASH MACULO-PAPULAR 230 0.0103
17 ORBITAL OEDEMA 5 0.0099
18 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 8 0.0097
19 TOXIC SKIN ERUPTION 97 0.0096
20 VIRAL VASCULITIS 1 0.0093
21 CHEST WALL TUMOUR 1 0.0083
22 RASH MORBILLIFORM 22 0.0079
23 CONTRAST MEDIA TOXICITY 1 0.0079
24 CONTRAST MEDIA ALLERGY 14 0.0076
25 MENINGITIS STAPHYLOCOCCAL 1 0.0070
26 SPINAL CORD INFARCTION 3 0.0068
27 CONTRAST MEDIA REACTION 16 0.0068
28 BENIGN NEOPLASM OF ADRENAL GLAND 1 0.0067
29 CARDIAC ASTHMA 1 0.0067
30 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 170 0.0066
31 BLADDER SPHINCTER ATONY 1 0.0065
32 EOSINOPHILIA 113 0.0064
33 FIXED ERUPTION 11 0.0064
34 NERVE CONDUCTION STUDIES ABNORMAL 1 0.0060
35 ADMINISTRATION SITE DISCOMFORT 1 0.0053
36 BAND NEUTROPHIL COUNT INCREASED 1 0.0051
37 CHEST WALL ABSCESS 1 0.0051
38 NORMOCHROMIC ANAEMIA 1 0.0050
39 GLOMERULONEPHRITIS ACUTE 1 0.0049
40 HISTAMINE LEVEL INCREASED 1 0.0046
41 COLD URTICARIA 1 0.0045
42 ALLERGY TEST POSITIVE 2 0.0044
43 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 1 0.0043
44 EPIGLOTTIC OEDEMA 1 0.0038
45 CYTOTOXIC OEDEMA 1 0.0038
46 CRYSTALLURIA 2 0.0037
47 CONTRAST ENCEPHALOPATHY 1 0.0036
48 SHUNT STENOSIS 1 0.0036
49 TRAUMATIC HAEMOTHORAX 1 0.0036
50 INFUSION SITE OEDEMA 3 0.0036
51 DERMATITIS EXFOLIATIVE GENERALISED 12 0.0034
52 BLOOD PRESSURE IMMEASURABLE 5 0.0033
53 VENOUS INJURY 3 0.0032
54 DERMATITIS BULLOUS 21 0.0029
55 MONOPARESIS 5 0.0028
56 WEANING FAILURE 1 0.0027
57 WRONG DRUG 1 0.0026
58 LIPOEDEMA 1 0.0025
59 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 2 0.0025
60 QUADRIPARESIS 4 0.0024
61 ANAL SPHINCTER ATONY 1 0.0023
62 HYPERFERRITINAEMIA 1 0.0023
63 TYPE I HYPERSENSITIVITY 8 0.0023
64 HYPERLEUKOCYTOSIS 2 0.0023
65 INFUSION SITE EXTRAVASATION 14 0.0022
66 MENINGOENCEPHALITIS HERPETIC 1 0.0022
67 MUCOSAL EROSION 2 0.0022
68 ISCHAEMIC HEPATITIS 3 0.0022
69 HERPES SIMPLEX ENCEPHALITIS 1 0.0022
70 SKIN TEST POSITIVE 2 0.0021
71 MENINGITIS BACTERIAL 3 0.0021
72 CEREBRAL HAEMATOMA 7 0.0021
73 TONGUE ERUPTION 1 0.0020
74 ADMINISTRATION SITE EXTRAVASATION 2 0.0020
75 HYPERCREATININAEMIA 1 0.0020
76 SHUNT OCCLUSION 1 0.0020
77 ANAPHYLACTIC SHOCK 50 0.0019
78 HEPATIC CYTOLYSIS 24 0.0019
79 BACTERIURIA 1 0.0018
80 SOFT TISSUE SWELLING 1 0.0018
81 INJECTION SITE OEDEMA 3 0.0017
82 VASCULAR PSEUDOANEURYSM 3 0.0017
83 TOXIC EPIDERMAL NECROLYSIS 26 0.0017
84 IRREGULAR BREATHING 1 0.0017
85 PURPURA 15 0.0017
86 EOSINOPHIL COUNT INCREASED 14 0.0017
87 DERMO-HYPODERMITIS 1 0.0017
88 MIXED LIVER INJURY 5 0.0017
89 MONOCYTOSIS 1 0.0016
90 EPSTEIN-BARR VIRUS TEST POSITIVE 1 0.0016
91 LARYNGEAL DISCOMFORT 1 0.0016
92 PUSTULAR PSORIASIS 5 0.0015
93 VASCULAR PURPURA 2 0.0014
94 PHARYNGEAL DISORDER 4 0.0014
95 SEBORRHOEIC KERATOSIS 2 0.0014
96 BRAIN CONTUSION 1 0.0014
97 NEUTROPHIL COUNT INCREASED 14 0.0014
98 RESPIRATORY TRACT OEDEMA 1 0.0013
99 BASOPHIL COUNT INCREASED 1 0.0013
100 HYPERTHYROIDISM 19 0.0013
101 NEUTROPHILIA 7 0.0012
102 VASOPLEGIA SYNDROME 2 0.0012
103 ARTHROPOD STING 2 0.0012
104 LOCALISED OEDEMA 5 0.0011
105 FACE OEDEMA 18 0.0011
106 PULPITIS DENTAL 1 0.0011
107 VASCULAR PAIN 1 0.0010
108 ANURIA 9 0.0010
109 RENAL TUBULAR NECROSIS 10 0.0010
110 HEMIANOPIA 1 0.0010
111 CORONARY ARTERY THROMBOSIS 2 0.0010
112 PULSELESS ELECTRICAL ACTIVITY 4 0.0010
113 VASCULAR OCCLUSION 2 0.0009
114 ACUTE KIDNEY INJURY 143 0.0009
115 LYMPHOCYTOSIS 2 0.0009
116 LIVER ABSCESS 3 0.0009
117 GASTROINTESTINAL TRACT IRRITATION 1 0.0009
118 VANISHING BILE DUCT SYNDROME 1 0.0009
119 MOANING 1 0.0009
120 BLOODY DISCHARGE 1 0.0009
121 AUTOIMMUNE HAEMOLYTIC ANAEMIA 3 0.0009
122 ADMINISTRATION SITE PAIN 1 0.0009
123 HYPERTENSIVE EMERGENCY 1 0.0008
124 STERNAL FRACTURE 1 0.0008
125 DERMATITIS EXFOLIATIVE 4 0.0008
126 NASAL PRURITUS 1 0.0008
127 PHYSICAL DECONDITIONING 2 0.0008
128 SLOW RESPONSE TO STIMULI 1 0.0008
129 MATERNAL EXPOSURE DURING BREAST FEEDING 3 0.0007
130 SIALOADENITIS 1 0.0007
131 HEPATOCELLULAR INJURY 10 0.0007
132 NORMOCYTIC ANAEMIA 1 0.0007
133 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
134 HYPERCAPNIA 2 0.0007
135 INFECTIOUS PLEURAL EFFUSION 1 0.0007
136 SKIN REACTION 9 0.0006
137 MULTIPLE ORGAN DYSFUNCTION SYNDROME 18 0.0006
138 FOREIGN BODY IN THROAT 2 0.0006
139 PULSE ABSENT 3 0.0006
140 CARDIO-RESPIRATORY ARREST 26 0.0006
141 HYPOVENTILATION 2 0.0006
142 RESUSCITATION 1 0.0006
143 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
144 SKIN NECROSIS 3 0.0006
145 PETECHIAE 6 0.0006
146 ANGIOEDEMA 25 0.0006
147 AORTIC VALVE STENOSIS 1 0.0006
148 RASH PUSTULAR 4 0.0005
149 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
150 NECROSIS 3 0.0005
151 GENERALISED ERYTHEMA 3 0.0005
152 MYELOPATHY 1 0.0005
153 ANAPHYLACTIC REACTION 29 0.0005
154 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
155 CHOLESTASIS 10 0.0005
156 PHARYNGEAL SWELLING 5 0.0005
157 ARTERIOSPASM CORONARY 2 0.0005
158 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
159 CONTRAINDICATED PRODUCT ADMINISTERED 15 0.0005
160 FOAMING AT MOUTH 1 0.0005
161 STEVENS-JOHNSON SYNDROME 11 0.0005
162 DERMATITIS PSORIASIFORM 1 0.0005
163 LARYNGEAL OEDEMA 3 0.0005
164 ANAPHYLACTOID REACTION 2 0.0005
165 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
166 NEUROGENIC BLADDER 1 0.0005
167 EAR SWELLING 1 0.0005
168 LIP OEDEMA 2 0.0005
169 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 11 0.0005
170 CHOLESTATIC LIVER INJURY 1 0.0004
171 NEPHROPATHY TOXIC 5 0.0004
172 ANAL INCONTINENCE 4 0.0004
173 DISTRIBUTIVE SHOCK 1 0.0004
174 LACTIC ACIDOSIS 14 0.0004
175 NEUROLOGICAL DECOMPENSATION 1 0.0004
176 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
177 ERYTHEMA MULTIFORME 4 0.0004
178 PATELLA FRACTURE 1 0.0004
179 PUSTULE 1 0.0004
180 PRE-ECLAMPSIA 2 0.0004
181 LONG QT SYNDROME 1 0.0004
182 PULSE ABNORMAL 1 0.0004
183 INJECTION SITE EXTRAVASATION 5 0.0004
184 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
185 VASODILATATION 1 0.0004
186 DRUG ERUPTION 7 0.0004
187 HAEMODYNAMIC INSTABILITY 3 0.0004
188 HYPERTHERMIA 3 0.0004
189 ISCHAEMIC STROKE 7 0.0004
190 PHLEBITIS 2 0.0004
191 TRISMUS 2 0.0004
192 COMPARTMENT SYNDROME 1 0.0004
193 YAWNING 1 0.0004
194 SKIN DISCOMFORT 1 0.0004
195 RASH PRURITIC 20 0.0004
196 ASPHYXIA 3 0.0004
197 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
198 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
199 ACUTE CORONARY SYNDROME 3 0.0004
200 ACUTE PULMONARY OEDEMA 2 0.0004
201 OXYGEN SATURATION ABNORMAL 1 0.0004
202 BRONCHOSPASM 5 0.0004
203 LIP PAIN 1 0.0003
204 HERPES VIRUS INFECTION 2 0.0003
205 STRIDOR 1 0.0003
206 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
207 URINARY INCONTINENCE 10 0.0003
208 CATARACT OPERATION 2 0.0003
209 METABOLIC ENCEPHALOPATHY 1 0.0003
210 OLIGURIA 2 0.0003
211 SWELLING OF EYELID 2 0.0003
212 CARDIAC ARREST 26 0.0003
213 BILE DUCT STONE 1 0.0003
214 SNEEZING 7 0.0003
215 UNRESPONSIVE TO STIMULI 8 0.0003
216 OEDEMA MOUTH 1 0.0003
217 ERYTHEMA 62 0.0003
218 LEFT VENTRICULAR FAILURE 1 0.0003
219 ENCEPHALITIS 2 0.0003
220 THROMBOPHLEBITIS 1 0.0003
221 COLD SWEAT 5 0.0003
222 JAUNDICE CHOLESTATIC 1 0.0003
223 FIBRIN D DIMER INCREASED 1 0.0003
224 CONJUNCTIVAL HYPERAEMIA 1 0.0003
225 CUTANEOUS VASCULITIS 1 0.0003
226 VENTRICULAR ARRHYTHMIA 1 0.0003
227 HYPOPHOSPHATAEMIA 2 0.0003
228 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
229 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
230 SNORING 1 0.0003
231 TONGUE OEDEMA 1 0.0003
232 ACIDOSIS 2 0.0003
233 METASTASES TO LUNG 3 0.0003
234 EYELID OEDEMA 3 0.0003
235 FAECES HARD 1 0.0003
236 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
237 CEREBRAL ATROPHY 1 0.0003
238 OXYGEN SATURATION DECREASED 14 0.0002
239 POLYURIA 2 0.0002
240 DEMYELINATION 1 0.0002
241 ARTHRITIS BACTERIAL 1 0.0002
242 HYPERURICAEMIA 1 0.0002
243 EXTRAVASATION 1 0.0002
244 GENERALISED OEDEMA 3 0.0002
245 HAEMODIALYSIS 2 0.0002
246 RASH GENERALISED 6 0.0002
247 RASH ERYTHEMATOUS 11 0.0002
248 SEPTIC SHOCK 10 0.0002
249 URTICARIA 38 0.0002
250 RASH PAPULAR 5 0.0002
251 MENINGITIS ASEPTIC 1 0.0002
252 SUSPECTED OFF LABEL USE 1 0.0002
253 TACHYPNOEA 3 0.0002
254 PALLOR 6 0.0002
255 IMMUNE THROMBOCYTOPENIA 1 0.0002
256 SHOCK 5 0.0002
257 RESPIRATORY DISTRESS 6 0.0002
258 PRURITUS 83 0.0002
259 THROMBOCYTOPENIA 24 0.0002
260 TACHYCARDIA 19 0.0002
261 SPINAL COLUMN STENOSIS 1 0.0002
262 LOSS OF CONSCIOUSNESS 27 0.0002
263 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
264 CARDIOGENIC SHOCK 3 0.0002
265 GUILLAIN-BARRE SYNDROME 1 0.0002
266 STAPHYLOCOCCAL SEPSIS 1 0.0002
267 CYTOKINE RELEASE SYNDROME 4 0.0002
268 TASTE DISORDER 4 0.0002
269 SUBARACHNOID HAEMORRHAGE 2 0.0002
270 PETIT MAL EPILEPSY 1 0.0002
271 RENAL FAILURE 26 0.0002
272 INJECTION SITE RASH 6 0.0002
273 HEPATITIS 5 0.0002
274 SERUM FERRITIN INCREASED 1 0.0002
275 SUDDEN DEATH 2 0.0002
276 NYSTAGMUS 1 0.0002
277 SEPSIS 21 0.0002
278 METABOLIC ACIDOSIS 6 0.0002
279 BRUXISM 1 0.0002
280 PRURITUS GENERALISED 4 0.0002
281 OEDEMA 10 0.0002
282 INTESTINAL ISCHAEMIA 1 0.0002
283 DENTAL CARIES 2 0.0002
284 BLOOD PRESSURE DECREASED 12 0.0002
285 VENTRICULAR FIBRILLATION 2 0.0002
286 HYPOTENSION 36 0.0002
287 INTRACRANIAL PRESSURE INCREASED 1 0.0002
288 HEART RATE ABNORMAL 1 0.0002
289 HYPERTONIA 1 0.0002
290 MUSCLE TWITCHING 4 0.0002
291 ENTEROCOLITIS 1 0.0002
292 RALES 1 0.0002
293 STRESS CARDIOMYOPATHY 1 0.0002
294 SKIN WARM 1 0.0002
295 HYPOVOLAEMIA 1 0.0002
296 HYPERTRIGLYCERIDAEMIA 1 0.0002
297 DERMATITIS ATOPIC 9 0.0002
298 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
299 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
300 PLEURISY 1 0.0002
301 PRODUCT PRESCRIBING ERROR 4 0.0002
302 ODYNOPHAGIA 1 0.0002
303 EPILEPSY 5 0.0002
304 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
305 PYREXIA 56 0.0002
306 AGRANULOCYTOSIS 3 0.0002
307 CHOLANGITIS 1 0.0002
308 DERMATITIS ALLERGIC 2 0.0002
309 HAEMATEMESIS 4 0.0002
310 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
311 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
312 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
313 FEELING HOT 9 0.0001
314 EYE MOVEMENT DISORDER 1 0.0001
315 RESPIRATORY ARREST 4 0.0001
316 RESPIRATION ABNORMAL 1 0.0001
317 DRUG INTERACTION 23 0.0001
318 BLISTER 8 0.0001
319 PAPULE 1 0.0001
320 NEUTROPENIA 19 0.0001
321 MOUTH HAEMORRHAGE 1 0.0001
322 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
323 SKIN HAEMORRHAGE 2 0.0001
324 PANCREATITIS ACUTE 3 0.0001
325 HYPOAESTHESIA ORAL 2 0.0001
326 APHASIA 4 0.0001
327 TROPONIN INCREASED 1 0.0001
328 HYPOKALAEMIA 6 0.0001
329 ATRIOVENTRICULAR BLOCK 1 0.0001
330 HYPOALBUMINAEMIA 1 0.0001
331 CYANOSIS 2 0.0001
332 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
333 NASAL DISCOMFORT 1 0.0001
334 LOW BIRTH WEIGHT BABY 1 0.0001
335 PREMATURE DELIVERY 2 0.0001
336 ATRIAL FLUTTER 1 0.0001
337 HYPOTHYROIDISM 4 0.0001
338 SHOCK HAEMORRHAGIC 1 0.0001
339 LUNG DISORDER 6 0.0001
340 EMBOLISM 1 0.0001
341 CHILLS 14 0.0001
342 SENSATION OF FOREIGN BODY 1 0.0001
343 INFUSION SITE ERYTHEMA 1 0.0001
344 HEMIPARESIS 2 0.0001
345 RASH 51 0.0001
346 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
347 HYPERHIDROSIS 15 0.0001
348 HAEMATOMA 3 0.0001
349 SKIN SWELLING 1 0.0001
350 RASH MACULAR 4 0.0001
351 HYPERKALAEMIA 4 0.0001
352 HEAD DISCOMFORT 2 0.0001
353 THROAT TIGHTNESS 3 0.0001
354 OROPHARYNGEAL DISCOMFORT 1 0.0001
355 DYSURIA 4 0.0001
356 SKIN EXFOLIATION 9 0.0001
357 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
358 EYE IRRITATION 6 0.0001
359 VITAMIN D DEFICIENCY 1 0.0001
360 CHOKING 2 0.0001
361 BLOOD PRESSURE ABNORMAL 2 0.0001
362 SYNCOPE 10 0.0001
363 BRAIN INJURY 1 0.0001
364 FLUSHING 10 0.0001
365 MOTOR DYSFUNCTION 1 0.0001
366 HYPERBILIRUBINAEMIA 1 0.0001
367 AGITATION 7 0.0001
368 BRADYCARDIA 5 0.0001
369 RETCHING 2 0.0001
370 BREAST CANCER METASTATIC 1 0.0001
371 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
372 ASPIRATION 1 0.0001
373 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
374 TRANSAMINASES INCREASED 2 0.0001
375 ORAL PAIN 2 0.0001
376 STATUS EPILEPTICUS 1 0.0001
377 MYOCARDIAL ISCHAEMIA 1 0.0001
378 MYOCARDITIS 1 0.0001
379 HYPERSENSITIVITY 16 0.0001
380 POST PROCEDURAL HAEMORRHAGE 1 0.0001
381 VASCULITIS 1 0.0001
382 HYPOXIA 3 0.0001
383 HYPERTENSION 18 0.0001
384 COMA 4 0.0001
385 MYOCLONUS 1 0.0001
386 MUSCLE RIGIDITY 1 0.0001
387 POLYNEUROPATHY 1 0.0001
388 PRESYNCOPE 2 0.0001
389 CEREBRAL INFARCTION 2 0.0001
390 LIVER INJURY 2 0.0001
391 INFUSION SITE PAIN 1 0.0001
392 SWELLING FACE 5 0.0001
393 PULMONARY CONGESTION 1 0.0001
394 JAUNDICE 2 0.0001
395 DYSPNOEA 42 0.0001
396 DISTURBANCE IN ATTENTION 4 0.0001
397 GINGIVAL BLEEDING 1 0.0001
398 ACUTE HEPATIC FAILURE 1 0.0001
399 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
400 FEELING COLD 2 0.0001
401 APHONIA 1 0.0001
402 SUBDURAL HAEMATOMA 1 0.0001
403 PARALYSIS 1 0.0001
404 ANGINA PECTORIS 2 0.0001
405 PARAESTHESIA ORAL 1 0.0001
406 ABDOMINAL PAIN 16 0.0001
407 FLUID OVERLOAD 1 0.0001
408 CHEST DISCOMFORT 7 0.0001
409 PREMATURE BABY 2 0.0001
410 LACRIMATION INCREASED 2 0.0001
411 PHARYNGEAL OEDEMA 1 0.0001
412 COGNITIVE DISORDER 3 0.0001
413 SWELLING 6 0.0001
414 SWOLLEN TONGUE 2 0.0001
415 MALAISE 28 0.0001
416 PNEUMOTHORAX 1 0.0001
417 CONFUSIONAL STATE 10 0.0001
418 SEIZURE 7 0.0001
419 VENTRICULAR TACHYCARDIA 1 0.0001
420 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
421 DRUG LEVEL INCREASED 1 0.0001
422 INFUSION RELATED REACTION 4 0.0001
423 OVERDOSE 13 0.0001
424 URINARY RETENTION 2 0.0001
425 CIRCULATORY COLLAPSE 1 0.0001
426 DELIRIUM 2 0.0001
427 NEOPLASM PROGRESSION 2 0.0001
428 OEDEMA PERIPHERAL 7 0.0001
429 LYMPHADENOPATHY 2 0.0001
430 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
431 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
432 THIRST 1 0.0001
433 CEREBRAL HAEMORRHAGE 2 0.0001
434 LEUKOCYTOSIS 1 0.0001
435 HYPERGLYCAEMIA 2 0.0001
436 RESPIRATORY FAILURE 4 0.0001
437 ACCIDENTAL OVERDOSE 2 0.0001
438 RESTLESSNESS 2 0.0001
439 TREMOR 9 0.0001
440 EYE SWELLING 2 0.0001
441 HEPATIC FUNCTION ABNORMAL 2 0.0001
442 BLOOD SODIUM DECREASED 1 0.0001
443 HYPOCALCAEMIA 1 0.0001
444 FEELING JITTERY 1 0.0001
445 BLOOD PRESSURE INCREASED 8 0.0001
446 WHEEZING 3 0.0001
447 COUGH 14 0.0000
448 PRODUCT ADMINISTRATION ERROR 1 0.0000
449 CONDITION AGGRAVATED 15 0.0000
450 BODY TEMPERATURE INCREASED 1 0.0000
451 RIB FRACTURE 1 0.0000
452 PERITONITIS 1 0.0000
453 RHABDOMYOLYSIS 2 0.0000
454 MOUTH ULCERATION 1 0.0000
455 RENAL FAILURE ACUTE 2 0.0000
456 BLOOD CREATININE INCREASED 3 0.0000
457 FEBRILE NEUTROPENIA 3 0.0000
458 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
459 VOMITING 21 0.0000
460 GLOSSODYNIA 1 0.0000
461 CHROMATURIA 1 0.0000
462 MUSCULAR WEAKNESS 5 0.0000
463 PERICARDIAL EFFUSION 1 0.0000
464 ARRHYTHMIA 2 0.0000
465 ANAEMIA 8 0.0000
466 PRODUCTIVE COUGH 2 0.0000
467 INTERSTITIAL LUNG DISEASE 2 0.0000
468 OFF LABEL USE 36 0.0000
469 ENCEPHALOPATHY 1 0.0000
470 DIARRHOEA 26 0.0000
471 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
472 DRY EYE 2 0.0000
473 PNEUMONIA ASPIRATION 1 0.0000
474 CARDIOVASCULAR DISORDER 1 0.0000
475 NAUSEA 31 0.0000
476 BLOOD BILIRUBIN INCREASED 1 0.0000
477 SKIN LESION 1 0.0000
478 MEDICATION ERROR 2 0.0000
479 HAEMOPTYSIS 1 0.0000
480 PANCYTOPENIA 2 0.0000
481 RENAL IMPAIRMENT 3 0.0000
482 CEREBROVASCULAR ACCIDENT 6 0.0000
483 DECREASED APPETITE 8 0.0000
484 MUSCULOSKELETAL STIFFNESS 3 0.0000
485 ACUTE MYOCARDIAL INFARCTION 1 0.0000
486 RESPIRATORY DISORDER 1 0.0000
487 HEPATIC FAILURE 1 0.0000
488 PLEURAL EFFUSION 2 0.0000
489 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
490 CHEST PAIN 6 0.0000
491 NERVOUS SYSTEM DISORDER 1 0.0000
492 DYSPHAGIA 3 0.0000
493 HEART RATE INCREASED 3 0.0000
494 LIP SWELLING 1 0.0000
495 SKIN DISORDER 1 0.0000
496 GAIT INABILITY 1 0.0000
497 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
498 HAEMATURIA 1 0.0000
499 ILLNESS 3 0.0000
500 HEART RATE DECREASED 1 0.0000
501 DIZZINESS 14 0.0000
502 PNEUMONIA 9 0.0000
503 CONSTIPATION 6 0.0000
504 C-REACTIVE PROTEIN INCREASED 1 0.0000
505 PANIC ATTACK 1 0.0000
506 DYSARTHRIA 1 0.0000
507 HALLUCINATION 2 0.0000
508 DIABETES MELLITUS 2 0.0000
509 PALPITATIONS 3 0.0000
510 DISORIENTATION 1 0.0000
511 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
512 DRY MOUTH 2 0.0000
513 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
514 NEUTROPHIL COUNT DECREASED 1 0.0000
515 POLLAKIURIA 1 0.0000
516 BALANCE DISORDER 2 0.0000
517 PULMONARY OEDEMA 1 0.0000
518 GASTROINTESTINAL DISORDER 2 0.0000
519 THROAT IRRITATION 1 0.0000
520 VISION BLURRED 3 0.0000
521 SKIN DISCOLOURATION 1 0.0000
522 BACK PAIN 5 0.0000
523 RENAL DISORDER 1 0.0000
524 PULMONARY EMBOLISM 2 0.0000
525 HYPOGLYCAEMIA 1 0.0000
526 ATRIAL FIBRILLATION 2 0.0000
527 PAIN IN EXTREMITY 6 0.0000
528 AGGRESSION 1 0.0000
529 SOMNOLENCE 4 0.0000
530 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
531 INFLAMMATION 1 0.0000
532 ABDOMINAL DISTENSION 2 0.0000
533 NERVOUSNESS 1 0.0000
534 ECZEMA 1 0.0000
535 SPEECH DISORDER 1 0.0000
536 PARAESTHESIA 3 0.0000
537 PLATELET COUNT DECREASED 2 0.0000
538 HYPONATRAEMIA 1 0.0000
539 PRODUCT SUBSTITUTION ISSUE 1 0.0000
540 DYSPHONIA 1 0.0000
541 NASAL CONGESTION 1 0.0000
542 STOMATITIS 1 0.0000
543 PRODUCT USE ISSUE 3 0.0000
544 RHINORRHOEA 1 0.0000
545 AMNESIA 1 0.0000
546 NEOPLASM MALIGNANT 1 0.0000
547 HEPATIC ENZYME INCREASED 1 0.0000
548 SLEEP DISORDER 1 0.0000
549 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
550 DYSGEUSIA 1 0.0000
551 EPISTAXIS 1 0.0000
552 ASTHENIA 5 0.0000
553 ACNE 1 0.0000
554 CHRONIC KIDNEY DISEASE 1 0.0000
555 PERIPHERAL SWELLING 2 0.0000
556 HEADACHE 8 0.0000
557 CARDIAC FAILURE 1 0.0000
558 PROSTATE CANCER 1 0.0000
559 INFLUENZA LIKE ILLNESS 1 0.0000
560 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
561 DRUG ABUSE 1 0.0000
562 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
563 URINARY TRACT INFECTION 2 0.0000
564 INTENTIONAL PRODUCT MISUSE 1 0.0000
565 MUSCLE SPASMS 2 0.0000
566 ADVERSE EVENT 1 0.0000
567 OROPHARYNGEAL PAIN 1 0.0000
568 GAIT DISTURBANCE 2 0.0000
569 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
570 FALL 3 0.0000
571 ASTHMA 1 0.0000
572 PAIN 5 0.0000
573 DEATH 7 0.0000
574 VISUAL IMPAIRMENT 1 0.0000
575 INJECTION SITE ERYTHEMA 1 0.0000
576 FATIGUE 6 0.0000
577 DEHYDRATION 1 0.0000
578 PRODUCT QUALITY ISSUE 1 0.0000
579 MEMORY IMPAIRMENT 1 0.0000
580 HYPOAESTHESIA 1 0.0000
581 INJECTION SITE PAIN 2 0.0000
582 ABDOMINAL DISCOMFORT 1 0.0000
583 TOXICITY TO VARIOUS AGENTS 1 0.0000
584 MYOCARDIAL INFARCTION 1 0.0000
585 COVID-19 1 0.0000
586 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
587 NO ADVERSE EVENT 1 0.0000
588 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
589 ABDOMINAL PAIN UPPER 1 0.0000
590 INCORRECT DOSE ADMINISTERED 1 0.0000
591 FEELING ABNORMAL 1 0.0000
592 ANXIETY 1 0.0000
593 DRUG INEFFECTIVE 1 0.0000